TGF-β1 mediates the radiation response of prostate cancer

被引:30
|
作者
Wu, Chun-Te [1 ,2 ]
Hsieh, Ching-Chuan [2 ,3 ]
Yen, Tzu-Chen [2 ,4 ,5 ]
Chen, Wen-Cheng [2 ,6 ]
Chen, Miao-Fen [2 ,6 ]
机构
[1] Chang Gung Mem Hosp, Dept Urol, Keelung, Taiwan
[2] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Dept Gen Surg, Chiayi, Taiwan
[4] Chang Gung Mem Hosp, Dept Nucl Med, Linkou, Taiwan
[5] Chang Gung Mem Hosp, Mol Imaging Ctr, Linkou, Taiwan
[6] Chang Gung Mem Hosp, Dept Radiat Oncol, Chiayi, Taiwan
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2015年 / 93卷 / 01期
关键词
TGF-beta; 1; Irradiation; Regulatory T cells; Prostate cancer; REGULATORY T-CELLS; GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; BREAST-CANCER; TUMOR MICROENVIRONMENT; HORMONE-THERAPY; PROGRESSION; RESISTANT; RADIOTHERAPY;
D O I
10.1007/s00109-014-1206-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Radiotherapy is the main treatment modality for prostate cancer. This study investigated the role of TGF-beta 1 in biological sequelae and tumor regrowth following irradiation, which are critical for the clinical radiation response of prostate cancer. Human and murine prostate cancer cell lines, and corresponding hormone-refractory (HR) cells, were used to examine the radiation response by clonogenic assays in vitro and tumor growth delay in vivo. Biological changes after irradiation, including cell death and tumor regrowth, were examined by experimental manipulation of TGF-beta 1 signaling. The correlations among tumor radiation responses, TGF-beta 1 levels, and regulatory T cells (Tregs) recruitment were also evaluated using animal experiments. HR prostate cancer cells appeared more radioresistant and had higher expression of TGF-beta 1 compared to hormone-sensitive (HS) cells. TGF-beta 1 expression was positively linked to irradiation and radioresistance, as demonstrated by in vitro and in vivo experiments. Inhibition of TGF-beta 1 increased tumor inhibition and DNA damage after irradiation. When mice were irradiated with a sub-lethal dose, the regrowth of irradiated tumors was significantly correlated with TGF-beta 1 levels and Tregs accumulation in vivo. Furthermore, blocking TGF-beta 1 clearly attenuated Tregs accumulation and tumor regrowth following treatment. These data demonstrate that TGF-beta 1 is important in determining the radiation response of prostate cancer, including tumor cell killing and the tumor microenvironment. Therefore, concurrent treatment with a TGF-beta 1 inhibitor is a potential therapeutic strategy for increasing the radiation response of prostate cancer, particularly for more aggressive or HR cancer cells. aEuro cent HR prostate cancer cells appeared more radioresistant and had higher expression of TGF-beta 1. aEuro cent TGF-beta 1 was positively linked to the radiation resistance of prostate cancer. aEuro cent Tumor regrowth following irradiation was significantly correlated with TGF-beta 1 and Tregs levels. aEuro cent Blocking TGF-beta 1 significantly attenuated RT-induced DNA repair and Tregs. aEuro cent TGF-beta 1 inhibitor increases the radiation response of HR cancer cells.
引用
收藏
页码:73 / 82
页数:10
相关论文
共 50 条
  • [21] BARD1 mediates TGF-β signaling in pulmonary fibrosis
    Pierre-Alain André
    Cecilia M. Prêle
    Sarah Vierkotten
    Stéphanie Carnesecchi
    Yves Donati
    Rachel C. Chambers
    Jean-Claude Pache
    Bruno Crestani
    Constance Barazzone-Argiroffo
    Melanie Königshoff
    Geoffrey J. Laurent
    Irmgard Irminger-Finger
    Respiratory Research, 16
  • [22] BARD1 mediates TGF-β signaling in pulmonary fibrosis
    Andre, Pierre-Alain
    Prele, Cecilia M.
    Vierkotten, Sarah
    Carnesecchi, Stephanie
    Donati, Yves
    Chambers, Rachel C.
    Pache, Jean-Claude
    Crestani, Bruno
    Barazzone-Argiroffo, Constance
    Koenigshoff, Melanie
    Laurent, Geoffrey J.
    Irminger-Finger, Irmgard
    RESPIRATORY RESEARCH, 2015, 16
  • [23] S100A4 mediates endometrial cancer invasion and is a target of TGF-β1 signaling
    Xie, Ran
    Schlumbrecht, Matthew P.
    Shipley, Gregory L.
    Xie, Susu
    Bassett, Roland L., Jr.
    Broaddus, Russell R.
    LABORATORY INVESTIGATION, 2009, 89 (08) : 937 - 947
  • [24] PAI-1 Mediates the TGF-β1+EGF-Induced "Scatter'' Response in Transformed Human Keratinocytes
    Freytag, Jennifer
    Wilkins-Port, Cynthia E.
    Higgins, Craig E.
    Higgins, Stephen P.
    Samarakoon, Rohan
    Higgins, Paul J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (09) : 2179 - 2190
  • [25] Down-regulation of TGF-β 1 production restores immunogenicity in prostate cancer cells
    E Matthews
    T Yang
    L Janulis
    S Goodwin
    S D Kundu
    W J Karpus
    C Lee
    British Journal of Cancer, 2000, 83 : 519 - 525
  • [26] Down-regulation of TGF-β1 production restores immunogenicity in prostate cancer cells
    Matthews, E.
    Yang, T.
    Janulis, L.
    Goodwin, S.
    Kundu, S. D.
    Karpus, W. J.
    Lee, C.
    BRITISH JOURNAL OF CANCER, 2000, 83 (04) : 519 - 525
  • [27] TGF-β1 regulates prostate cancer-bone marrow endothelial cell interactions
    Miles, F.
    van Golen, K. L.
    Duncan, R. L.
    Sikes, R. A.
    Cooper, C. R.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 60 - 60
  • [28] The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone
    Fournier, Pierrick G. J.
    Juarez, Patricia
    Jiang, Guanglong
    Clines, Gregory A.
    Niewolna, Maria
    Kim, Hun Soo
    Walton, Holly W.
    Peng, Xiang Hong
    Liu, Yunlong
    Mohammad, Khalid S.
    Wells, Clark D.
    Chirgwin, John M.
    Guise, Theresa A.
    CANCER CELL, 2015, 27 (06) : 809 - 821
  • [29] A positive feedback loop between TGF-β and SCF mediates TGF-β1 ligand overexpression in advanced hepatocellular carcinoma
    Zhang, Pingyu
    Rojas, Andres
    Wang, Ying
    Munoz, Nina M.
    Xiao, Lianchun
    Wang, Jing
    Gores, Gregory J.
    Hung, Mien-Chie
    Blechacz, Boris R. A.
    CANCER RESEARCH, 2015, 75
  • [30] Autocrine TGF-β1 mediates angiotensin II-Induced proliferative response of cerebral vessels in vivo
    Yurovsky, Vladimir V.
    Gerzanich, Volodymyr
    Ivanova, Svetlana
    Dong, Yafeng
    Tsymbalyuk, Orest
    Simard, J. Marc
    AMERICAN JOURNAL OF HYPERTENSION, 2007, 20 (09) : 950 - 956